These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36334358)

  • 121. Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer.
    Zhang Y; Fu F; Wen Z; Deng L; Wang S; Li Y; Chen H
    Ann Thorac Surg; 2020 Apr; 109(4):1061-1068. PubMed ID: 31863756
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Quantifying the number of lymph nodes for examination in breast cancer.
    Sun L; Li P; Ren H; Liu G; Sun L
    J Int Med Res; 2020 Feb; 48(2):300060519879594. PubMed ID: 31640445
    [TBL] [Abstract][Full Text] [Related]  

  • 123. How many lymph nodes should be dissected in esophagectomy with or without neoadjuvant therapy to get accurate staging?
    Zhan C; Shi Y; Jiang W; Sun F; Li M; Lu T; Yin J; Ma K; Yang X; Wang Q
    Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 30997490
    [TBL] [Abstract][Full Text] [Related]  

  • 124. How to evaluate the adequacy of staging for nodal-negative epithelial ovarian cancer? Use of nodal staging score.
    Xu Y; Li H; Tong X; Pang Y; Tong X; Li L; Cheng L
    J Gynecol Oncol; 2019 Mar; 30(2):e21. PubMed ID: 30740953
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.
    Hua J; Zhang B; Xu J; Liu J; Ni Q; He J; Zheng L; Yu X; Shi S
    Eur J Surg Oncol; 2019 Jun; 45(6):1069-1076. PubMed ID: 30685327
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Pathological nodal staging score for rectal cancer patients treated with radical surgery with or without neoadjuvant therapy: a postoperative decision tool.
    Dai W; Li Y; Wu Z; Feng Y; Cai S; Xu Y; Li Q; Cai G
    Cancer Manag Res; 2019; 11():537-546. PubMed ID: 30662284
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Nodal staging score and adequacy of nodal staging.
    Chen HM; Feng G
    Onco Targets Ther; 2019; 12():449-455. PubMed ID: 30662271
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.
    Rieken M; Boorjian SA; Kluth LA; Capitanio U; Briganti A; Thompson RH; Leibovich BC; Krabbe LM; Margulis V; Raman JD; Regelman M; Karakiewicz PI; Rouprêt M; Abufaraj M; Foerster B; Gönen M; Shariat SF
    World J Urol; 2019 Aug; 37(8):1631-1637. PubMed ID: 30406477
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2018 Oct; 106(4):989-997. PubMed ID: 29852148
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    Cheng X; Zheng D; Li Y; Li H; Sun Y; Xiang J; Chen H
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2648-2656.e2. PubMed ID: 29548592
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scores.
    Wu Z; Qin G; Zhao N; Jia H; Zheng X
    BMC Cancer; 2017 Jul; 17(1):498. PubMed ID: 28743236
    [TBL] [Abstract][Full Text] [Related]  

  • 133. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
    Amin MB; Greene FL; Edge SB; Compton CC; Gershenwald JE; Brookland RK; Meyer L; Gress DM; Byrd DR; Winchester DP
    CA Cancer J Clin; 2017 Mar; 67(2):93-99. PubMed ID: 28094848
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
    Liang W; He J; Shen Y; Shen J; He Q; Zhang J; Jiang G; Wang Q; Liu L; Gao S; Liu D; Wang Z; Zhu Z; Ng CS; Liu CC; Petersen RH; Rocco G; D'Amico T; Brunelli A; Chen H; Zhi X; Liu B; Yang Y; Chen W; Zhou Q; He J
    J Clin Oncol; 2017 Apr; 35(11):1162-1170. PubMed ID: 28029318
    [TBL] [Abstract][Full Text] [Related]  

  • 135. How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.
    Robinson TJ; Thomas S; Dinan MA; Roman S; Sosa JA; Hyslop T
    J Clin Oncol; 2016 Oct; 34(28):3434-9. PubMed ID: 27528716
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.
    Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Seitz C; Sun M; Karakiewicz PI; Schramek P; Herman MP; Becker A; Hansen J; Ehdaie B; Loidl W; Pummer K; Lee RK; Lotan Y; Scherr DS; Seiler D; Ahyai SA; Chun FK; Graefen M; Tewari A; Nonis A; Bachmann A; Montorsi F; Gönen M; Briganti A; Shariat SF
    Br J Cancer; 2014 Jul; 111(2):213-9. PubMed ID: 25003663
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer.
    Osarogiagbon RU; Ogbata O; Yu X
    Ann Thorac Surg; 2014 Feb; 97(2):385-93. PubMed ID: 24266949
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.
    Nitadori J; Bograd AJ; Kadota K; Sima CS; Rizk NP; Morales EA; Rusch VW; Travis WD; Adusumilli PS
    J Natl Cancer Inst; 2013 Aug; 105(16):1212-20. PubMed ID: 23926067
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer.
    Osarogiagbon RU; Yu X
    Ann Thorac Surg; 2013 Oct; 96(4):1178-1189. PubMed ID: 23910633
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Identification of stage I non-small cell lung cancer patients at high risk for local recurrence following sublobar resection.
    Varlotto JM; Medford-Davis LN; Recht A; Flickinger J; Yao N; Hess C; Reed MF; Toth J; Zander DS; DeCamp MM
    Chest; 2013 May; 143(5):1365-1377. PubMed ID: 23715196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.